Explore this research category across breast cancer datasets
| RNA Name | Mechanism of Action | Effect on Cancer | Cancer Type | Reference |
|---|---|---|---|---|
|
PBRC
lncRNA |
Induces autophagy to promote breast cancer progression | PRBC induces autophagy by modulating PABPC1-mediated mRNA stabilization | Breast Cancer |
PubMed
Reference PMID: 38366145 |
|
LINC01016
lncRNA |
Regulates autophagy through miR-302a-3p and SATB1 interaction. | Associated with survival prognosis in breast cancer | Breast Cancer |
PubMed
Reference PMID: 33216456 |
|
LINC00578
lncRNA |
Induces autophagy-related oncogenic pathways | Correlated with poor prognosis in breast cancer | Breast Cancer |
PubMed
Reference PMID: 33216456 |
|
LINC01614
lncRNA |
Regulates SLC31A1 expression as part of the LINC01614/miR-204-5p/SLC31A1 axis | Associated with poor prognosis and immune infiltration | Breast Cancer |
PubMed
Reference PMID: 37884650 |
|
USP2-AS1
lncRNA |
Part of a prognostic 2-lncRNA signature (BCCuS) impacting copper-induced cell death pathways | Predicts breast cancer prognosis and immune dysfunction | Breast Cancer |
PubMed
Reference PMID: 36699089 |
|
NIFK-AS1
lncRNA |
Works in conjunction with USP2-AS1 in the BCCuS signature | Predicts sensitivity to therapies and patient survival | Breast Cancer |
PubMed
Reference PMID: 36699089 |
|
C6orf99
lncRNA |
Regulates DLD mRNA via miR-370-3p and miR-432-5p in the cuproptosis pathway | Associated with endocrine therapy resistance in ER+ BC | Breast Cancer |
PubMed
Reference PMID: 37143115 |
|
CARMN
lncRNA |
Involved in the PRNP/miRNA hsa-miR-192-5p and hsa-miR-215-5p/lncRNA CARMN ceRNA network | Regulates PRNP in cuproptosis in breast cancer | Breast Cancer |
PubMed
Reference PMID: 36980514 |
|
LINC01863
lncRNA |
Impacts cell proliferation in BC, associated with drug sensitivity | Role in immune infiltration and therapeutic responses | Breast Cancer |
PubMed
Reference PMID: 38772805 |
|
AC104211.1
lncRNA |
Similar role as LINC01863, influencing BC cell viability and sensitivity to therapies | Prognostic and therapeutic implications | Breast Cancer |
PubMed
Reference PMID: 38772805 |